ReP USP - Resultado da busca

Artigo de periodico
Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis (2019)
Pardeo, Manuela; Wang, Jianmei; Ruperto, Nicolino; Alexeeva, Ekaterina; Chasnyk, Vyacheslav; Schneider, Rayfel; Horneff, Gerd; Huppertz, Hans-Iko; Minden, Kirsten; Silva, Clovis Artur Almeida da
Fonte: Journal of rheumatology. Unidade: FM
Assuntos: ARTRITE REUMATOIDE JUVENIL, NEUTRÓFILOS, FÁRMACOS ANTIRREUMÁTICOS, INFECÇÕES OPORTUNISTAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARDEO, Manuela et al. Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis. Journal of rheumatology, v. 46, n. 9, p. 1117-1126, 2019Tradução . . Disponível em: https://doi.org/10.3899/jrheum.180795. Acesso em: 23 jul. 2024.
APA
Pardeo, M., Wang, J., Ruperto, N., Alexeeva, E., Chasnyk, V., Schneider, R., et al. (2019). Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis. Journal of rheumatology, 46( 9), 1117-1126. doi:10.3899/jrheum.180795
NLM
Pardeo M, Wang J, Ruperto N, Alexeeva E, Chasnyk V, Schneider R, Horneff G, Huppertz H-I, Minden K, Silva CAA da. Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis [Internet]. Journal of rheumatology. 2019 ; 46( 9): 1117-1126.[citado 2024 jul. 23 ] Available from: https://doi.org/10.3899/jrheum.180795
Vancouver
Pardeo M, Wang J, Ruperto N, Alexeeva E, Chasnyk V, Schneider R, Horneff G, Huppertz H-I, Minden K, Silva CAA da. Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis [Internet]. Journal of rheumatology. 2019 ; 46( 9): 1117-1126.[citado 2024 jul. 23 ] Available from: https://doi.org/10.3899/jrheum.180795
Artigo de periodico
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial (2015)
Brunner, Hermine I.; Ruperto, Nicolino; Zuber, Zbigniew; Keane, Caroline; Harari, Olivier; Kenwright, Andrew; Lu, Peng; Cuttica, Ruben; Keltsev, Vladimir; Xavier, Ricardo M.; Calvo, Inmaculada; Nikishina, Irina; Rubio-Pérez, Nadina; Alexeeva, Ekaterina; Chasnyk, Vyacheslav; Horneff, Gerd; Opoka-Winiarska, Violetta; Quartier, Pierre; Silva, Clovis A.; Silverman, Earl; Spindler, Alberto; Baildam, Eileen; Gámir, M. Luz; Martin, Alan; Rietschel, Christoph; Siri, Daniel; Smolewska, Elzbieta; Lovell, Daniel; Martini, Alberto; De Benedetti, Fabrizio
Fonte: Annals of the Rheumatic Diseases. Unidade: FM
Assuntos: ANTICORPOS MONOCLONAIS (EFICIÊNCIA;SEGURANÇA), ARTRITE REUMATOIDE, MÉTODO DUPLO-CEGO, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUNNER, Hermine I. et al. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial. Annals of the Rheumatic Diseases, v. 74, n. 6, p. 1110-1117, 2015Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2014-205351. Acesso em: 23 jul. 2024.
APA
Brunner, H. I., Ruperto, N., Zuber, Z., Keane, C., Harari, O., Kenwright, A., et al. (2015). Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial. Annals of the Rheumatic Diseases, 74( 6), 1110-1117. doi:10.1136/annrheumdis-2014-205351
NLM
Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, Lu P, Cuttica R, Keltsev V, Xavier RM, Calvo I, Nikishina I, Rubio-Pérez N, Alexeeva E, Chasnyk V, Horneff G, Opoka-Winiarska V, Quartier P, Silva CA, Silverman E, Spindler A, Baildam E, Gámir ML, Martin A, Rietschel C, Siri D, Smolewska E, Lovell D, Martini A, De Benedetti F. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial [Internet]. Annals of the Rheumatic Diseases. 2015 ; 74( 6): 1110-1117.[citado 2024 jul. 23 ] Available from: https://doi.org/10.1136/annrheumdis-2014-205351
Vancouver
Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, Lu P, Cuttica R, Keltsev V, Xavier RM, Calvo I, Nikishina I, Rubio-Pérez N, Alexeeva E, Chasnyk V, Horneff G, Opoka-Winiarska V, Quartier P, Silva CA, Silverman E, Spindler A, Baildam E, Gámir ML, Martin A, Rietschel C, Siri D, Smolewska E, Lovell D, Martini A, De Benedetti F. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial [Internet]. Annals of the Rheumatic Diseases. 2015 ; 74( 6): 1110-1117.[citado 2024 jul. 23 ] Available from: https://doi.org/10.1136/annrheumdis-2014-205351
Artigo de periodico
Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years (2015)
Lovell, Daniel J.; Ruperto, Nicolino; Mouy, Richard; Paz, Eliana; Rubio-Pérez, Nadina; Silva, Clovis A.; Abud-Mendoza, Carlos; Burgos-Vargas, Ruben; Gerloni, Valeria; Melo-Gomes, Jose A.; Saad-Magalhaes, Claudia; Chavez-Corrales, J.; Huemer, Christian; Kivitz, Alan; Blanco, Francisco J.; Foeldvari, Ivan; Hofer, Michael; Huppertz, Hans-Iko; Deslandre, Chantal Job; Minden, Kirsten; Punaro, Marilynn; Block, Alan J.; Giannini, Edward H.; Martini, Alberto
Fonte: Arthritis and Rheumatology. Unidade: FM
Assuntos: DOENÇA CRÔNICA, MEDICAÇÃO INTRAVENOSA, QUALIDADE DE VIDA, ARTRITE REUMATÓIDE JUVENIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOVELL, Daniel J. et al. Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years. Arthritis and Rheumatology, v. 67, n. 10, p. 2759-2770, 2015Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/art.39234/pdf. Acesso em: 23 jul. 2024.
APA
Lovell, D. J., Ruperto, N., Mouy, R., Paz, E., Rubio-Pérez, N., Silva, C. A., et al. (2015). Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years. Arthritis and Rheumatology, 67( 10), 2759-2770. doi:10.1002/art.39234
NLM
Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhaes C, Chavez-Corrales J, Huemer C, Kivitz A, Blanco FJ, Foeldvari I, Hofer M, Huppertz H-I, Deslandre CJ, Minden K, Punaro M, Block AJ, Giannini EH, Martini A. Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years [Internet]. Arthritis and Rheumatology. 2015 ; 67( 10): 2759-2770.[citado 2024 jul. 23 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39234/pdf
Vancouver
Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhaes C, Chavez-Corrales J, Huemer C, Kivitz A, Blanco FJ, Foeldvari I, Hofer M, Huppertz H-I, Deslandre CJ, Minden K, Punaro M, Block AJ, Giannini EH, Martini A. Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years [Internet]. Arthritis and Rheumatology. 2015 ; 67( 10): 2759-2770.[citado 2024 jul. 23 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39234/pdf
Artigo de periodico
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis (2013)
Lazarevic, Dragana; Pistorio, Angela; Palmisani, Elena; Miettunen, Paivi; Ravelli, Angelo; Pilkington, Clarissa; Wulffraat, Nico M.; Malattia, Clara; Garay, Stella Maris; Hofer, Michael; Quartier, Pierre; Dolezalova, Pavla; Penades, Inmaculada Calvo; Ferriani, Virgínia Paes Leme; Ganser, Gerd; Kasapcopur, Ozgur; Melo-Gomes, José Antonio; Reed, Ann M.; Wierzbowska, Malgorzata; Rider, Lisa G.; Martini, Alberto; Ruperto, Nicolino
Fonte: Annals of the Rheumatic Diseases. Unidade: FMRP
Assuntos: DERMATOPATIAS, DOENÇAS MUSCULOSQUELÉTICAS, REUMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAZAREVIC, Dragana et al. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Annals of the Rheumatic Diseases, v. 72, n. 5, p. 686-693, 2013Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2012-201483. Acesso em: 23 jul. 2024.
APA
Lazarevic, D., Pistorio, A., Palmisani, E., Miettunen, P., Ravelli, A., Pilkington, C., et al. (2013). The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Annals of the Rheumatic Diseases, 72( 5), 686-693. doi:10.1136/annrheumdis-2012-201483
NLM
Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C, Wulffraat NM, Malattia C, Garay SM, Hofer M, Quartier P, Dolezalova P, Penades IC, Ferriani VPL, Ganser G, Kasapcopur O, Melo-Gomes JA, Reed AM, Wierzbowska M, Rider LG, Martini A, Ruperto N. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis [Internet]. Annals of the Rheumatic Diseases. 2013 ; 72( 5): 686-693.[citado 2024 jul. 23 ] Available from: https://doi.org/10.1136/annrheumdis-2012-201483
Vancouver
Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C, Wulffraat NM, Malattia C, Garay SM, Hofer M, Quartier P, Dolezalova P, Penades IC, Ferriani VPL, Ganser G, Kasapcopur O, Melo-Gomes JA, Reed AM, Wierzbowska M, Rider LG, Martini A, Ruperto N. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis [Internet]. Annals of the Rheumatic Diseases. 2013 ; 72( 5): 686-693.[citado 2024 jul. 23 ] Available from: https://doi.org/10.1136/annrheumdis-2012-201483
Artigo de periodico
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial (2010)
Foell, Dirk; Wulffraat, Nico; Garay, Stella; Vojinovic, Jelena; Norambuena, Ximena; Gamir, María Luz; Consuegra, Julia García; Lepore, Loredana; Susic, Gordana; Corona, Fabrizia; Dolezalova, Pavla; Pistorio, Angela; Martini, Alberto; Ruperto, Nicolino; Roth, johannes; Wedderburn, Lucy R.; Wittkowski, Helmut; Frosch, Michael; Gerf, Joachim; Stanevicha, Valda; Mihaylova, Dimitrina; Ferriani, Virgínia Paes Leme; Tsakalidou, Florence Kanakoudi; Foeldvari, Ivan; Cuttica, Ruben; Gonzalez, Benito; Ravelli, Angelo; khubchandani, Raju; Oliveira, Sheila; Armbrust, Wineke
Fonte: JAMA: The Journal of the American Medical Association. Unidade: FMRP
Assuntos: ARTRITE REUMATOIDE JUVENIL, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOELL, Dirk et al. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association, v. 303, n. 13, p. 1266-1273, 2010Tradução . . Acesso em: 23 jul. 2024.
APA
Foell, D., Wulffraat, N., Garay, S., Vojinovic, J., Norambuena, X., Gamir, M. L., et al. (2010). Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association, 303( 13), 1266-1273.
NLM
Foell D, Wulffraat N, Garay S, Vojinovic J, Norambuena X, Gamir ML, Consuegra JG, Lepore L, Susic G, Corona F, Dolezalova P, Pistorio A, Martini A, Ruperto N, Roth johannes, Wedderburn LR, Wittkowski H, Frosch M, Gerf J, Stanevicha V, Mihaylova D, Ferriani VPL, Tsakalidou FK, Foeldvari I, Cuttica R, Gonzalez B, Ravelli A, khubchandani R, Oliveira S, Armbrust W. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association. 2010 ; 303( 13): 1266-1273.[citado 2024 jul. 23 ]
Vancouver
Foell D, Wulffraat N, Garay S, Vojinovic J, Norambuena X, Gamir ML, Consuegra JG, Lepore L, Susic G, Corona F, Dolezalova P, Pistorio A, Martini A, Ruperto N, Roth johannes, Wedderburn LR, Wittkowski H, Frosch M, Gerf J, Stanevicha V, Mihaylova D, Ferriani VPL, Tsakalidou FK, Foeldvari I, Cuttica R, Gonzalez B, Ravelli A, khubchandani R, Oliveira S, Armbrust W. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association. 2010 ; 303( 13): 1266-1273.[citado 2024 jul. 23 ]
Artigo de periodico
Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients (2010)
Ravelli, Angelo; Trail, Lucia; Zulian, Francesco; Baca, Vicente; Cortis, Elisabetta; Falcini, Fernanda; Alessio, Maria; Alpigiani, Maria Giannina; Gerloni, Valeria; Magalhães, Claudia Saad; Podda, Rosana; Silva, Clovis A.; Lepore, Loredana; Felici, Enrico; Rossi, Federica; Sala, Elena; Martini, Alberto; Ferrari, Cristina; Ruperto, Nicolino; Pistorio, Angela; Pilkington, Clarissa; Maillard, , Susan; Oliveira, Sheila K.; Sztajnbok, Flavio; Cuttica, Ruben; Beltramelli, Matilde; Corona, Fabrizia; Katsicas, Maria Martha; Russo, Ricardo; Ferriani, Virgínia Paes Leme; Vargas, Ruben Burgos; Manzoni, Silvia Magni; Vallejo, Eunice Solis; Bandeira, Marcia
Fonte: Arthritis Care and Research. Unidade: FMRP
Assuntos: DOENÇAS MUSCULOSQUELÉTICAS, PROGNÓSTICO, DERMATOPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAVELLI, Angelo et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care and Research, v. 62, n. 1, p. 63-72, 2010Tradução . . Disponível em: https://doi.org/10.1002/acr.20015. Acesso em: 23 jul. 2024.
APA
Ravelli, A., Trail, L., Zulian, F., Baca, V., Cortis, E., Falcini, F., et al. (2010). Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care and Research, 62( 1), 63-72. doi:10.1002/acr.20015
NLM
Ravelli A, Trail L, Zulian F, Baca V, Cortis E, Falcini F, Alessio M, Alpigiani MG, Gerloni V, Magalhães CS, Podda R, Silva CA, Lepore L, Felici E, Rossi F, Sala E, Martini A, Ferrari C, Ruperto N, Pistorio A, Pilkington C, Maillard, Oliveira SK, Sztajnbok F, Cuttica R, Beltramelli M, Corona F, Katsicas MM, Russo R, Ferriani VPL, Vargas RB, Manzoni SM, Vallejo ES, Bandeira M. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients [Internet]. Arthritis Care and Research. 2010 ; 62( 1): 63-72.[citado 2024 jul. 23 ] Available from: https://doi.org/10.1002/acr.20015
Vancouver
Ravelli A, Trail L, Zulian F, Baca V, Cortis E, Falcini F, Alessio M, Alpigiani MG, Gerloni V, Magalhães CS, Podda R, Silva CA, Lepore L, Felici E, Rossi F, Sala E, Martini A, Ferrari C, Ruperto N, Pistorio A, Pilkington C, Maillard, Oliveira SK, Sztajnbok F, Cuttica R, Beltramelli M, Corona F, Katsicas MM, Russo R, Ferriani VPL, Vargas RB, Manzoni SM, Vallejo ES, Bandeira M. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients [Internet]. Arthritis Care and Research. 2010 ; 62( 1): 63-72.[citado 2024 jul. 23 ] Available from: https://doi.org/10.1002/acr.20015
Trabalho de evento-resumo periodico
A randomised trial of 6 months versus 12 months withdrawal of methotrexate in children with juvenile idiopathic arthritis in clinical remission (2009)
Foell, David; Wulffraat, N.; Wedderburn, L. R.; Pistorio, Angela; Ravelli, Angelo; Stanevicha, Valda; Mihaylova, D.; Ferriani, Virgínia Paes Leme; Tsakalidou, F. Kanakoudi; Foeldvari, Ivan; Cuttica, R.; Gonzalez, B.; Khubchandani, R.; Oliveira, S. K. F.; Armbrust, W.; Garay, Stuart M.; Vojinovic, J.; Norambuena, X.; Gamir, M.; Consuegra, J. Garcia; Lepore, L.; Susic, G.; Corona, Fernando; Dolezalova, P.; Saurenmann, T.; Uziel, Y.; Martini, A.; Ruperto, Nicolino
Fonte: Annals of the Rheumatic Diseases. Nome do evento: Annual European Congres of Rheumatology. Unidade: FMRP
Assuntos: ARTRITE REUMATOIDE JUVENIL, COMPOSTOS HETEROCÍCLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOELL, David et al. A randomised trial of 6 months versus 12 months withdrawal of methotrexate in children with juvenile idiopathic arthritis in clinical remission. Annals of the Rheumatic Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 23 jul. 2024. , 2009
APA
Foell, D., Wulffraat, N., Wedderburn, L. R., Pistorio, A., Ravelli, A., Stanevicha, V., et al. (2009). A randomised trial of 6 months versus 12 months withdrawal of methotrexate in children with juvenile idiopathic arthritis in clinical remission. Annals of the Rheumatic Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Foell D, Wulffraat N, Wedderburn LR, Pistorio A, Ravelli A, Stanevicha V, Mihaylova D, Ferriani VPL, Tsakalidou FK, Foeldvari I, Cuttica R, Gonzalez B, Khubchandani R, Oliveira SKF, Armbrust W, Garay SM, Vojinovic J, Norambuena X, Gamir M, Consuegra JG, Lepore L, Susic G, Corona F, Dolezalova P, Saurenmann T, Uziel Y, Martini A, Ruperto N. A randomised trial of 6 months versus 12 months withdrawal of methotrexate in children with juvenile idiopathic arthritis in clinical remission. Annals of the Rheumatic Diseases. 2009 ; 68( suppl. 3): 307.[citado 2024 jul. 23 ]
Vancouver
Foell D, Wulffraat N, Wedderburn LR, Pistorio A, Ravelli A, Stanevicha V, Mihaylova D, Ferriani VPL, Tsakalidou FK, Foeldvari I, Cuttica R, Gonzalez B, Khubchandani R, Oliveira SKF, Armbrust W, Garay SM, Vojinovic J, Norambuena X, Gamir M, Consuegra JG, Lepore L, Susic G, Corona F, Dolezalova P, Saurenmann T, Uziel Y, Martini A, Ruperto N. A randomised trial of 6 months versus 12 months withdrawal of methotrexate in children with juvenile idiopathic arthritis in clinical remission. Annals of the Rheumatic Diseases. 2009 ; 68( suppl. 3): 307.[citado 2024 jul. 23 ]
Artigo de periodico
The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study (2008)
Ruperto, Nicolino; Ravelli, Angelo; Pistorio, Angela; Ferriani, Virgínia Paes Leme; Calvo, Immaculada; Ganser, Gerd; Brunner, Jurgen; Dannecker, Guenther; Silva, Clovis Artur Almeida da; Stanevicha, Valda; Cate, Rebecca Ten; Van Suijlekom-Smit, Lisette W. A.; Voygioyka, Olga; Fischbach, Michel; Foeldvari, Ivan; Hilario, Odete; Modesto, Consuelo; Saurenmann, Rotraud K.; Sauvain, Marie-Josephe; Scheibel, Iloite; Sommelet, Danièle; Tambic-Bukovac, Lana; Barcellona, Roberto; Brik, Riva; Ehl, Stephan; Jovanovic, Mirjana; Rovensky, Josef; Bagnasco, Francesca; Lovell, Daniel J.; Martini, Alberto
Fonte: Arthritis and Rheumatism. Unidade: FMRP
Assuntos: DERMATOMICOSES, REUMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUPERTO, Nicolino et al. The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis and Rheumatism, v. 59, n. 1, p. 4-13, 2008Tradução . . Disponível em: https://doi.org/10.1002/art.23248. Acesso em: 23 jul. 2024.
APA
Ruperto, N., Ravelli, A., Pistorio, A., Ferriani, V. P. L., Calvo, I., Ganser, G., et al. (2008). The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis and Rheumatism, 59( 1), 4-13. doi:10.1002/art.23248
NLM
Ruperto N, Ravelli A, Pistorio A, Ferriani VPL, Calvo I, Ganser G, Brunner J, Dannecker G, Silva CAA da, Stanevicha V, Cate RT, Van Suijlekom-Smit LWA, Voygioyka O, Fischbach M, Foeldvari I, Hilario O, Modesto C, Saurenmann RK, Sauvain M-J, Scheibel I, Sommelet D, Tambic-Bukovac L, Barcellona R, Brik R, Ehl S, Jovanovic M, Rovensky J, Bagnasco F, Lovell DJ, Martini A. The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study [Internet]. Arthritis and Rheumatism. 2008 ; 59( 1): 4-13.[citado 2024 jul. 23 ] Available from: https://doi.org/10.1002/art.23248
Vancouver
Ruperto N, Ravelli A, Pistorio A, Ferriani VPL, Calvo I, Ganser G, Brunner J, Dannecker G, Silva CAA da, Stanevicha V, Cate RT, Van Suijlekom-Smit LWA, Voygioyka O, Fischbach M, Foeldvari I, Hilario O, Modesto C, Saurenmann RK, Sauvain M-J, Scheibel I, Sommelet D, Tambic-Bukovac L, Barcellona R, Brik R, Ehl S, Jovanovic M, Rovensky J, Bagnasco F, Lovell DJ, Martini A. The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study [Internet]. Arthritis and Rheumatism. 2008 ; 59( 1): 4-13.[citado 2024 jul. 23 ] Available from: https://doi.org/10.1002/art.23248

Unidades USP

ReP

Filtros

Autores

Ano de publicação

Assuntos

Título da fonte

Indexado em

Afiliação dos autores externos não normalizada